Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHofstraat, S H I
Falla, A M
Duffell, E F
Hahné, S J M
Amato-Gauci, A J
Veldhuijzen, I K
MetadataShow full item record
TitleCurrent prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
Published inEpidemiol Infect 2017, 145(14):2873-85
PubliekssamenvattingThis systematic review aimed at estimating chronic hepatitis B (HBV) and C virus (HCV) prevalence in the European Union (EU) and Economic Area (EEA) countries in the general population, blood donors and pregnant women. We searched PubMed©, Embase© and Cochrane Library databases for reports on HBV and HCV prevalence in the general population and pregnant women in EU/EEA countries published between 2005 and 2015. Council of Europe data were used for HBV and HCV blood donor prevalence. HBV general population estimates were available for 13 countries, ranging from 0·1% to 4·4%. HCV general population estimates were available for 13 countries, ranging from 0·1% to 5·9%. Based on general population and blood donor estimates, the overall HBV prevalence in the EU/EEA is estimated to be 0·9% (95% CI 0·7-1·2), corresponding to almost 4·7 million HBsAg-positive cases; and the overall HCV prevalence to be 1·1% (95% CI 0·9-1·4), equalling 5·6 million anti-HCV-positive cases. We found wide variation in HCV and HBV prevalence across EU/EEA countries for which estimates were available, as well as variability between groups often considered a proxy for the general population. Prevalence estimates are essential to inform policymaking and public health practice. Comparing to other regions globally, HBV and HCV prevalence in the EU/EEA is low.
- Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
- Authors: Falla AM, Ahmad AA, Duffell E, Noori T, Veldhuijzen IK
- Issue date: 2018 Jan 16
- Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
- Authors: Falla AM, Hofstraat SHI, Duffell E, Hahné SJM, Tavoschi L, Veldhuijzen IK
- Issue date: 2018 Feb 12
- Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
- Authors: Aspinall EJ, Hutchinson SJ, Goldberg DJ, Valerio H, Mozalevskis A, Noori T, Duffell E, Tavoschi L
- Issue date: 2018 Feb
- Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
- Authors: Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L
- Issue date: 2019 Jul
- Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
- Authors: Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv
- Issue date: 2013 Apr 18